John Overdeck’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,108
Closed -$11K 3146
2022
Q3
$11K Buy
+12,108
New +$14.7K ﹤0.01% 2415
2022
Q2
Sell
-198,759
Closed -$276K 3057
2022
Q1
$276K Sell
198,759
-40,251
-17% -$86.1K ﹤0.01% 2238
2021
Q4
$815K Buy
239,010
+55,163
+30% +$311K ﹤0.01% 2743
2021
Q3
$1.63M Buy
+183,847
New +$2.42M ﹤0.01% 2176
2021
Q2
Sell
-88,742
Closed -$1.19M 4694
2021
Q1
$1.19M Buy
+88,742
New +$2M ﹤0.01% 2151

Other funds holding AFIB

John Overdeck's AFIB Position: Q4 2022 in Review

John Overdeck sold out of Acutus Medical Inc (AFIB) in Q4 2022, closing a stake of 12,108 shares — an estimated $11K sold.

John Overdeck first reported a position in AFIB in Q1 2021 and held it in 5 quarters. The position peaked at $1.63M in Q3 2021. 38 funds tracked by Wall St. Rank hold AFIB as of Q4 2022.

  • John Overdeck reported no remaining Acutus Medical Inc position as of Q4 2022 after selling out during the quarter.
  • John Overdeck sold 12,108 Acutus Medical Inc shares in Q4 2022, an estimated $11K.
  • John Overdeck first reported a position in Acutus Medical Inc in Q1 2021 and held it in 5 quarters.
  • John Overdeck's Acutus Medical Inc position peaked at $1.63M in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.